Cargando…
Acquired hypofibrinogenemia: current perspectives
Acquired hypofibrinogenemia is most frequently caused by hemodilution and consumption of clotting factors. The aggressive replacement of fibrinogen has become one of the core principles of modern management of massive hemorrhage. The best method for determining the patient’s fibrinogen level remains...
Autores principales: | Besser, Martin W, MacDonald, Stephen G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045218/ https://www.ncbi.nlm.nih.gov/pubmed/27713652 http://dx.doi.org/10.2147/JBM.S90693 |
Ejemplares similares
-
Hereditary Hypofibrinogenemia with Hepatic Storage
por: Asselta, Rosanna, et al.
Publicado: (2020) -
Transient hypofibrinogenemia due to allopurinol
por: Yin, ZhiQiang, et al.
Publicado: (2014) -
Risk factors and clinical outcomes associated with acquired hypofibrinogenemia in patients administered hemocoagulase batroxobin for hemoptysis
por: Lee, Jae-Kyeong, et al.
Publicado: (2022) -
Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021) -
Total knee arthroplasty in a patient with hypofibrinogenemia
por: Nacca, Christopher R., et al.
Publicado: (2015)